Mutation in the kras gene as a predictor of the effectiveness of immunotherapy for non-small cell lung cancer

Mutation in the kras gene as a predictor of the effectiveness of immunotherapy for non-small cell lung cancer

The purpose of the study: to conduct a systematic literature review on the effectiveness and feasibility of using information on the presence of KRAS gene mutations (in different codons), TP 53 (KP), ST K11/LKB1 (KL), and KEAP mutations and the association of KRAS m with PD -L1 status in patients wi...

Full description

Saved in:
Bibliographic Details
Main Authors: K. K. Laktionov, A. M. Kazakov, K. A. Sarantseva, D. S. Scherbo, A. P. Koval
Format: Article
Language:Russian
Published: Russian Academy of Sciences, Tomsk National Research Medical Center 2022-03-01
Series:Сибирский онкологический журнал
Subjects:
immunotherapy
kras mutation
pd1-l1 status
co-mutations
liquid biopsy
Online Access:https://www.siboncoj.ru/jour/article/view/2035
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.siboncoj.ru/jour/article/view/2035

Similar Items